Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 14, 2014 - Issue 5
Submit an article Journal homepage
1,392
Views
11
CrossRef citations to date
0
Altmetric
Editorial

Co-stimulatory blockade with belatacept in kidney transplantation

Bhavna ChopraAllegheny General Hospital, Division of Nephrology and Hypertension, Department of Medicine, 320 East North Avenue, Pittsburgh, PA 15212, USA+1 412 359 3319; +1 412 359 4136;[email protected]
, MD &
Kalathil K SureshkumarAllegheny General Hospital, Division of Nephrology and Hypertension, Department of Medicine, 320 East North Avenue, Pittsburgh, PA 15212, USA+1 412 359 3319; +1 412 359 4136;[email protected]
, MD FRCP FASN
Pages 563-567 | Published online: 12 Mar 2014

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Paolo Malvezzi & Lionel Rostaing. (2015) The safety of calcineurin inhibitors for kidney-transplant patients. Expert Opinion on Drug Safety 14:10, pages 1531-1546.
Read now

Articles from other publishers (10)

Jonathan H. Pelletier, Emeraghi E. David, Annabelle N. Chua & Eileen Tsai Chambers. 2019. Adolescents with Chronic Kidney Disease. Adolescents with Chronic Kidney Disease 247 268 .
Jiandong Lu, Jinting Peng, Min Xiang, Liangping He, Dongcai Wang, Guoliang Xiong & Shunmin Li. (2018) Trichosanthes kirilowii lectin alleviates diabetic nephropathy by inhibiting the LOX1/NF-κB/caspase-9 signaling pathway . Bioscience Reports 38:5.
Crossref
Rui Xue, Dingkun Gui, Liyang Zheng, Ruonan Zhai, Feng Wang & Niansong Wang. (2017) Mechanistic Insight and Management of Diabetic Nephropathy: Recent Progress and Future Perspective. Journal of Diabetes Research 2017, pages 1-7.
Crossref
Shinsuke Oshima, Erik E. Karrer, Yuka Kawato, Masashi Maeda, Hidehiko Fukahori, Susumu Tsujimoto, Jun Hirose, Koji Nakamura, Takanori Marui, Fujiko Takamura, Takahisa Noto, Steven J. Chapin, Yasutomo Fujii, Margaret Neighbors, Sridhar Viswanathan, Bruce H. Devens & Yasuyuki Higashi. (2016) The Effect of ASP2409, a Novel CD86-Selective Variant of CTLA4-Ig, on Renal Allograft Rejection in Nonhuman Primates. Transplantation 100:12, pages 2611-2620.
Crossref
Shinsuke Oshima, Yasutomo Fujii, Erik E. Karrer, Fujiko Takamura, Steven J. Chapin, Margaret Neighbors, Sridhar Viswanathan, Bruce H. Devens, Yasuyuki Higashi & Hidekazu Mizuhara. (2016) Immunosuppressive effect of ASP2408, a novel CD86-selective variant of CTLA4-Ig, in rats and cynomolgus monkeys. International Immunopharmacology 40, pages 310-317.
Crossref
Tong Zhu, James Keirns, Corrie Howieson, Atsunori Kaibara, Ronald Goldwater, Alan J. Kivitz, Vishala Chindalore, Stanley Cohen, Vicki Santos, Bolanle Akinlade, Robert Kernstock, Leticia Delgado-Herrera, Paul C Blahunka, Erik E. Karrer, Jay P. Garg, Nancy Samberg & Bernhardt G. Zeiher. (2016) Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of ASP2408, a Potent Selective T-Cell Costimulation Modulator After Single and Multiple Ascending Doses in Healthy Volunteers and RA Patients. Clinical Pharmacology in Drug Development 5:5, pages 408-425.
Crossref
Sandeep K. MallipattuJohn C. He. (2016) The podocyte as a direct target for treatment of glomerular disease?. American Journal of Physiology-Renal Physiology 311:1, pages F46-F51.
Crossref
Wenhui Zhang, Robert M. Kernstock, Erik E. Karrer, Stanley B. Cohen, Vishala L. Chindalore, Alan J. Kivitz, Paul C. Blahunka, Leticia Delgado-Herrera, Bernhardt G. Zeiher, Nancy L. Samberg & Jay P. Garg. (2016) A Phase 1 Dose-Escalation Study of ASP2409, a Selective T-Cell Costimulation Inhibitor, in Stable Rheumatoid Arthritis Patients on Methotrexate Therapy. Clinical Pharmacology in Drug Development 5:4, pages 259-268.
Crossref
Gerald J. Berry & Randall E. Morris. 2016. Pathology of Transplantation. Pathology of Transplantation 53 79 .
Tae-Hyun Yoo & Alessia Fornoni. (2015) Nonimmunologic targets of immunosuppressive agents in podocytes. Kidney Research and Clinical Practice 34:2, pages 69-75.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.